The 6 analysts offering 12 month price targets for Cronos Group Inc have a median target of 3.90, with a high estimate of 4.25 and a low estimate of 3.00. The median estimate represents a 74.89% increase from the last price of 2.23.
The House of Commons Health Committee will reconvene in Ottawa a week ahead of Parliament resuming to hold full-day hearings on the government's marijuana legalization bill. The committee is holding the marathon session of meetings to get a head start on its study of Bill C-45, the Cannabis Act. "It's going to be all day… nine to five and then some," health committee chair, Liberal MP Bill Casey, told CTV News.